$GNSS

Genasys (GNSS) Q3 2026 Earnings Call Transcript

Genasys (GNSS) reported Q3 2026 revenue of $7.3M, down from $9.9M YoY, citing supply chain issues and Puerto Rico project delays. Software revenue rose 21% YoY to $2.7M, boosting gross margin to 57.1%. The company reported a net loss of $4.7M, improved from $6.5M YoY. Backlog grew to $69M, and cash reserves fell to $3.1M. Management noted new orders from the U.S. Army and a major utility, and extended a $15.2M term loan.

Original reporting
Published Aug 20, 2026, 11:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 21, 2026, 12:10 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Genasys (GNSS) Q3 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$GNSSNeutralHigh
01

Why it matters

Earnings release provides fresh data on revenue trends, margin improvement, and contract pipeline, informing short‑term trading decisions.

02

Market read

Micro‑cap earnings with mixed results; investors will focus on software growth and backlog visibility.

03

What to watch

Cash runway is limited; reliance on a few large contracts adds concentration risk.

Relevance 6/10Novelty 7/10Timing: post-market release

Background

Genasys Inc. provides public safety acoustic warning systems; the Q3 2026 call details financial performance and new contracts.

Company-level read

Ticker impact

$GNSSNeutralMedium confidence
Context

Q3 2026 earnings released with revenue $7.3M, GAAP loss $4.7M and new $9M CROWS contract.

Expected impact

Potential modest upside if guidance holds, but volatility expected.

Evidence & confidence

Revenue decline and cash burn raise concerns, while software growth and backlog support price.

Market effects

Highlights demand for public safety acoustic devices and software in emergency alert market.

U.S. defense and utility contracts may boost related suppliers.

International navy interest could broaden addressable market.

Counterpoint

Despite revenue decline, strong software mix and backlog could drive a rebound.

Key entities

  • Genasys Inc.

    Public safety acoustic and software solutions provider.

  • U.S. Army

    Awarded $3M acoustics order.

Related articles

$GNSSMed

Genasys Inc. (GNSS): Results of Operations and Financial Condition

Genasys Inc. (GNSS) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 gnss-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Genasys Inc. Reports Fiscal Third Quarter 2026 Results SAN DIEGO, CA – August 13, 2026 – Genasys Inc. (NASDAQ: GNSS), the global leader in Protective Communications®, today announced full financial results for the Company’s f

$UPSHighAI 8/10

UPS Stopped Carrying 2 Million Amazon Packages a Day. Amazon Still Has to Move Them.

UPS completed its 18-month plan to reduce Amazon shipments, cutting 2 million packages daily and $4.5B in related costs. UPS's Q2 U.S. revenue rose 6% with a 9.3% increase in revenue per piece. Amazon's shipping costs increased 19% to $27.9B in Q2, outpacing its 15% online sales growth. Amazon is expanding its delivery network, handling 6.7B U.S. parcels in 2025, making it the largest parcel carrier.

$SNOWHighAI 8/10

2 Software Stocks That Whale Rock Is Betting Will Survive the Apocalypse

Snowflake (SNOW) reported Q1 FY2026 with GAAP net loss narrowing to $295.6M, adjusted EPS of $0.39, and raised fiscal 2027 revenue outlook to $5.8B. Twilio (TWLO) reported Q2 2026 revenue of $1.5B, non-GAAP EPS of $1.47, and raised full-year 2026 revenue growth outlook to 18-18.5%. Both stocks have 'Strong Buy' consensus ratings.

$AZNHighAI 8/10

AstraZeneca’s Earnings Beat Shows Momentum, But Can its Pipeline Deliver $80 Billion in Revenue?

AstraZeneca (NYSE:AZN) reported H1 2026 earnings with core EPS of $2.63, beating estimates. Revenue rose 6%, driven by 16% growth in oncology and 11% in rare diseases. The company aims for $80B revenue by 2030, with JPMorgan analysts viewing the target as achievable. Despite recent clinical setbacks, AstraZeneca maintained its 2026 outlook, expecting mid-to-high-single-digit revenue growth and low-double-digit core EPS growth.

$DINOHighAI 8/10

HF Sinclair posts a profit and closes its only Canadian lubricant (base oil) refinery. Not because of no profits, but it is not worth doing business with Net Zero Leadership.

HF Sinclair (NYSE: DINO) reported Q2 2026 net income of $892M, up from prior-year levels, and announced it will close its Mississauga, Ontario base oil refinery. The company plans to spin off its Lubricants & Specialties segment into a separate publicly traded company. The decision is driven by a strategic shift to a capital-light model, despite the segment's strong profitability. The refinery's closure is expected to be completed by 2027, with supply shifting to long-term agreements with Chevro